Apimeds Pharmaceuticals Us I shares owned by UBS Group
Quarter-by-quarter ownership of Apimeds Pharmaceuticals Us I (APUS) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Apimeds Pharmaceuticals Us I
Tip: Access up to 7 years of quarterly data
All positions including Apimeds Pharmaceuticals Us I held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apimeds Pharmaceuticals Us I by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $954 | 582 | 1.64 |